Letter to editor regarding a review of MF59-adjuvanted influenza vaccine by Gartner et al

被引：1
|
作者：
Yin, J. Kevin [1 ,2 ]
Harris, Rebecca C. [3 ,4 ]
Loiacono, Matthew M. [5 ]
Chit, Ayman [6 ]
Samson, Sandrine I. [6 ,7 ]
机构：
[1] Sanofi, Global Med Affairs, Singapore, Singapore
[2] Univ Sydney, Sydney, NSW, Australia
[3] Sanofi, Global Med Evidence Generat, Singapore, Singapore
[4] London Sch Hyg & Trop Med, London, England
[5] Sanofi, Global Med Evidence Generat, Swiftwater, PA USA
[6] Sanofi, Global Med Affairs, Lyon, France
[7] Univ Toronto, Toronto, ON, Canada
来源：
VACCINE | 2023年 / 41卷 / 27期
关键词：
D O I：
10.1016/j.vaccine.2022.12.034
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3948 / 3948
页数：1
相关论文
共 50 条
  • [31] Improved immunologic responses to heterologous influenza strains in children with low preexisting antibody response vaccinated with MF59-adjuvanted influenza vaccine
    Palladino, Giuseppe
    Ferrari, Annette
    Music, Nedzad
    Settembre, Ethan C.
    Wen, Yingxia
    VACCINE, 2021, 39 (38) : 5351 - 5357
  • [32] Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults
    Song, Joon Young
    Cheong, Hee Jin
    Tsai, T. F.
    Chang, Hyun-ah
    Choi, Min Joo
    Jeon, Ji Ho
    Kang, Seong Hee
    Jeong, Eun Ju
    Noh, Ji Yun
    Kim, Woo Joo
    VACCINE, 2015, 33 (36) : 4647 - 4652
  • [33] Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis
    Black, Steven
    Della Cioppa, Giovanni
    Malfroot, Anne
    Nacci, Pantaleo
    Nicolay, Uwe
    Pellegrini, Michele
    Sokal, Etienne
    Vertruyen, Andre
    VACCINE, 2010, 28 (45) : 7331 - 7336
  • [34] Cost effectiveness of MF59 adjuvanted influenza vaccine in France
    Chambers, J.
    Eijgelshoven, I
    Piercy, J.
    Wait, S.
    VALUE IN HEALTH, 2007, 10 (03) : A163 - A164
  • [35] MF59™-adjuvanted seasonal influenza vaccine in young children
    Puig-Barbera, Joan
    Perez-Vilar, Silvia
    Diez-Domingo, Javier
    EXPERT REVIEW OF VACCINES, 2011, 10 (11) : 1519 - 1528
  • [36] Comparison of the Immunogenicity and Safety of the Conventional Subunit, MF59-Adjuvanted, and Intradermal Influenza Vaccines in the Elderly
    Bin Seo, Yu
    Choi, Won Suk
    Lee, Jacob
    Song, Joon Young
    Cheong, Hee Jin
    Kim, Woo Joo
    CLINICAL AND VACCINE IMMUNOLOGY, 2014, 21 (07) : 989 - 996
  • [37] Long-term and cross-reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59-adjuvanted vaccine versus unadjuvanted vaccine
    Song, Joon Young
    Cheong, Hee Jin
    Noh, Ji Yun
    Seo, Yu Bin
    Choi, Won Suk
    Cho, Geum Joo
    Hwang, Taik Gun
    Kim, Woo Joo
    JOURNAL OF MEDICAL VIROLOGY, 2013, 85 (09) : 1591 - 1597
  • [38] MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database
    Pellegrini, Michele
    Nicolay, Uwe
    Lindert, Kelly
    Groth, Nicola
    Della Cioppa, Giovanni
    VACCINE, 2009, 27 (49) : 6959 - 6965
  • [39] MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk
    Durando, Paolo
    Icardi, Giancarlo
    Ansaldi, Filippo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (04) : 639 - 651
  • [40] MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico
    Cruz-Valdez, Aurelio
    Valdez-Zapata, Gabriel
    Patel, Sanjay S.
    Castelli, Flavia V.
    Garcia, Marcia G.
    Jansen, Wim T.
    Arora, Ashwani Kumar
    Heijnen, Esther
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (02) : 386 - 395
12345